title: Cancer Liquid Biopsy: Is It Ready for Clinic?
abstract: The management of cancer relies on a combination of imaging and tissue biopsy for diagnosis, monitoring, and molecular classification-based patient stratification to ensure appropriate treatment. Conventional tissue biopsy harvests tumor samples with invasive procedures, which are often difficult for patients with advanced disease. Given the well-recognized intratumor genetic heterogeneity [1], the biopsy of small tumor fragments does not necessarily represent all the genetic aberrations in the tumor, but sampling the entire tumor in each patient is not realistic. Moreover, tumors evolve all the time from local to advanced disease and by adapting to selective pressure from treatment.
authors.forename: Ying
authors.initials: Y
authors.lastname: Pan
authors.forename: John S
authors.initials: JS
authors.lastname: Ji
authors.forename: Jason Gang
authors.initials: JG
authors.lastname: Jin
authors.forename: Winston Patrick
authors.initials: WP
authors.lastname: Kuo
authors.forename: Hongjun
authors.initials: H
authors.lastname: Kang
mesh_terms: D001706:Biopsy / Q000379:methods*; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis / Q000473:pathology